Navigation Links
Parametrics Medical, LLC Announces the Release of Their Coll-e-Strong Line of Soft Tissue Allografts
Date:5/8/2013

ROUND ROCK, Texas, May 8, 2013 /PRNewswire/ -- Parametrics Medical, LLC, a private tissue bank specializing in providing the most diverse supply of allografts available in the market, announces its release of their Coll-e-Strong line of soft tissue allografts.  Parametrics Medical utilizes Electron Beam sterilization, or E-Beam Technology, to terminally sterilize the tissue without compromising the biomechanical properties of the collagen.  The Coll-e-Strong line of allografts is the first to bridge the gap between biomechanics and sterility. 

Electron beam sterilization provides several advantages over current allograft processing methods.  Safety is of the utmost concern for orthopedic surgeons today.  It is imperative to have an allograft that is terminally sterile with a one in one million (1/1,000,000) chance of bio burden living in the tissue.  Several preferred methods in the market today can only provide a one in one thousand (1/1,000) chance.  Historically, sterilization processes which render a terminally sterile graft weaken the biomechanical properties of the tissue.  Coll-e-Strong offers surgeons the distinct advantage of terminal sterility with no clinical change in the biomechanical properties of the soft tissue.

The anterior cruciate ligament (ACL) reconstruction is one of the most prominent surgeries related to sports injuries; Most notably, NFL superstars Adrian Peterson and Robert Griffin III along with soon-to-be MLB hall of famer, Mariano Rivera , have all undergone ACL reconstruction.  The surgeon has a choice between an allograft, which comes from tissue donors, and an autograft, which is typically a tendon taken from another part of the patient's body and repurposed for the ACL.  Surgeons use allografts from tissue donors on roughly 40% of all ACL procedures.  The use of allograft tissue in these procedures reduces the length of the surgery, the amount of trauma in the surgery, and reduces the pain post operatively.  These factors contribute to better outcomes, lower costs and higher patient satisfaction.

Dan Leary , Vice President and General Manager of Parametrics Medical, said, "The release of our Coll-e-Strong line of allografts gives surgeons the opportunity to have the best of both worlds.  It has been a constant challenge for the orthopedic surgeon to choose between safety and efficacy.  Coll-e-Strong removes the stress of that decision because it provides both.  We believe our Coll-e-Strong line of sports medicine allografts will become the industry standard.  For the first time, surgeons can have an allograft with strength qualities equivalent to an autograft that is also truly sterile." 

About Parametrics Medical, LLC:

Parametrics Medical serves the orthopedic community by providing the most diverse supply of allograft tissue coupled with the industry's best customer service.  Parametrics Medical has succeeded at providing the most current technologies in allograft bone and soft tissue processing spanning all specialties within orthopedics to include sports medicine, trauma, joint reconstruction and spine.  Parametrics Medical is able to provide for every processing and preservation technique on the market through their world-class industry partnerships.  It is through these manufacturing partnerships that Parametrics Medical is able to continually be on the forefront of technology and ensure their customers are able to support all of their surgeon's demands.  To find out more about Parametrics Medical and their new Coll-e-Strong line of allografts, please visit them at www.parametricsmedical.com.  You can also download the latest studies, literature and videos at the links below:

Coll-e-Strong Processing Video

Coll-e-Strong White Paper

Coll-e-Strong Collagen Review

Coll-e-Strong Q&A


'/>"/>
SOURCE Parametrics Medical, LLC
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Haemonetics Completes Hemerus Medical, LLC Acquisition
2. Haemonetics Reports 4th Quarter Fiscal 2013 Revenue Up 34% and Adjusted EPS of $0.48; Fourth Quarter and Full Year Organic Revenue Up 4% and Full Year Adjusted EPS of $1.71; Completes Hemerus Medical, LLC Acquisition and Provides Fiscal 2014 Guidanc
3. Acutus Medical, Inc. erprobt erstmals seinen Echtzeit-3D-Bildgebungskatheter von CT/MRI-Qualität in einer klinischen Studie am Menschen
4. Acutus Medical, Inc. lance la première étude clinique sur lhomme dun cathéter à imagerie 3D en temps réel offrant une qualité comparable aux TDM/IRM
5. Acutus Medical, Inc. Initiates "First-In-Man" Clinical Study of Real-Time 3D Imaging Catheter with CT/MRI Quality
6. Chindex-Fosun Pharma Joint Venture, Chindex Medical, To Participate in Acquisition of Alma Lasers; Fosun Pharma Increases Investment in Chindex Medical
7. Positive Data, Pipeline Improvements & Market Expansion - Research Report on Abbott Laboratories, Stryker Corporation, St. Jude Medical, Cardiovascular Systems and MAKO Surgical
8. Vasomedical, Inc. Investor Presentation Now Available for On-demand Viewing at RetailInvestorConferences.com
9. Aethlon Medical, Inc. Investor Presentation Now Available for On-demand Viewing at RetailInvestorConferences.com
10. Vasomedical, Inc. to Present Live Webcast at RetailInvestorConferences.com on February 7th
11. TI introduces lowest-power octal, 100-MSPS ADC for medical, industrial imaging applications
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/9/2016)... Fla. , Dec. 9, 2016  Harmar Mobility, LLC announced ... and a member of the Board of Directors. Photo ... ... Mr. Dawson,s ... development of organizations across a variety of industries. He brings to ...
(Date:12/9/2016)... -- Research and Markets has announced the addition of ... offering. ... global travel vaccines market to grow at a CAGR of 6.83% ... scenario and the growth prospects of the global travel vaccines market ... revenue generated from the sales of various vaccines administered to actively ...
(Date:12/8/2016)... -- IRIDEX Corporation (NASDAQ: IRIX ) today announced ... stock, $0.01 par value (the "Offering" with such shares being ... terms of the Offering will depend on market and other ... no assurance as to whether or when the Offering may ... proceeds it will receive from this offering for working capital ...
Breaking Medicine Technology:
(Date:12/9/2016)... PA (PRWEB) , ... December 09, 2016 , ... "I ... Fla. "I used this old family recipe, which is meant to relieve gout and ... it gave me a 12-hour energy boost every time. It relieved what VA doctors ...
(Date:12/9/2016)... ... December 09, 2016 , ... The Holy ... in New York, NY, on December 3rd, to benefit Holy Name Medical Center's ... annual event, which raised over $1 million - the largest event in the ...
(Date:12/8/2016)... ... December 08, 2016 , ... The Florida Hospital ... and Hyperbaric Medical Society (UHMS), the leading authority in hyperbaric medicine. This accreditation ... a few hospitals and facilities have earned this distinction. This is the second ...
(Date:12/8/2016)... ... December 08, 2016 , ... Mirixa Corporation ... adherence, and other pharmacist-delivered patient care services, has announced the promotions of Karen ... to vice president of sales. , Litsinger joined Mirixa in 2008 after ...
(Date:12/8/2016)... ... December 08, 2016 , ... SunView ... customers and employees that are both engaging and easy to use. Coming off ... the software company revealed today its plans to roll out new AI-powered self-service ...
Breaking Medicine News(10 mins):